معرفی
Per Sandström serves as an Adjunct Professor at Linköping University within the Department of Biomedical and Clinical Sciences (BKV), affiliated with the Faculty of Medicine and Health Sciences. He is actively embedded in the Division of Surgery, Orthopedics and Oncology (KOO), focusing on translational clinical research in surgical oncology and hepatobiliary diseases.
His research spans hepato-pancreato-biliary surgery, colorectal cancer molecular mechanisms, and health-related quality of life assessment. Key interests include postoperative liver failure prediction using advanced imaging, molecular pathways in cancer metastasis (particularly TBX3-Wnt interactions), and validation of patient-reported outcome measures. His work bridges experimental surgery techniques with clinical patient-centered outcomes.
Analysis of his 2025 publications reveals a strong Scandinavian collaborative focus on high-impact clinical questions: prospective quality-of-life studies in cancer surgery, MRI-based liver function assessment, portal vein embolization outcomes, and molecular metastasis drivers. These works demonstrate integration of surgical innovation, molecular biology, and patient experience metrics across hepatic and colorectal oncology.
Dr. Sandström operates within Linköping University's Division of Surgery, Orthopedics and Oncology (KOO)—a research-intensive unit conducting experimental and clinical studies in surgical oncology. This division forms part of the Department of Biomedical and Clinical Sciences, one of the university's largest departments with extensive interdisciplinary capacity in biomedical research and clinical translation.
